ACS Nano 15 (7), 1234212357
What Medications Are Available Today for SUD (and How They Work) Treatment options for substance use disorders vary by substance, with differing levels of regulatory approval, efficacy, and patient suitability
Additional mechanistic investigations have implicated BPC-157 in the modulation of the FAK-paxillin pathway, a key regulator of focal adhesion dynamics and cytoskeletal organization
Protamine-derived permeation enhancers represent one of the most exciting developments
Tumor necrosis factor receptor-associated factor 6 (TRAF6) is a key downstream mediator of the CD40L-CD40-TRAF6 axis in macrophages
Peter Malliaras et al., Achilles and patellar tendinopathy loading programmes: A systematic review comparing clinical outcomes and identifying potential mechanisms for effectiveness, Sports medicine (Auckland, N.Z.) 43, no